Pacer Advisors Inc. grew its holdings in Colgate-Palmolive Company (NYSE:CL) by 8.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,224 shares of the company’s stock after purchasing an additional 1,566 shares during the period. Pacer Advisors Inc.’s holdings in Colgate-Palmolive were worth $1,499,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. TIAA CREF Investment Management LLC grew its stake in shares of Colgate-Palmolive by 84.2% in the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after buying an additional 2,082,262 shares in the last quarter. Swiss National Bank grew its stake in shares of Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock valued at $268,393,000 after buying an additional 666,400 shares in the last quarter. MARSHALL WACE ASIA Ltd grew its stake in shares of Colgate-Palmolive by 1,419.1% in the second quarter. MARSHALL WACE ASIA Ltd now owns 518,823 shares of the company’s stock valued at $38,393,000 after buying an additional 484,670 shares in the last quarter. British Airways Pensions Investment Management Ltd bought a new position in shares of Colgate-Palmolive in the second quarter valued at $34,347,000. Finally, Pioneer Investment Management Inc. grew its stake in shares of Colgate-Palmolive by 27.8% in the second quarter. Pioneer Investment Management Inc. now owns 2,061,196 shares of the company’s stock valued at $152,796,000 after buying an additional 447,949 shares in the last quarter. Institutional investors own 73.45% of the company’s stock.
A number of equities analysts have commented on the stock. Stifel Nicolaus set a $73.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a research report on Monday, September 25th. Deutsche Bank AG reaffirmed a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a research report on Monday, July 24th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. Finally, BidaskClub cut shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research report on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $76.98.
Colgate-Palmolive Company (NYSE CL) opened at 70.40 on Monday. The stock has a 50 day moving average price of $72.80 and a 200 day moving average price of $73.14. The firm has a market cap of $62.01 billion, a P/E ratio of 26.16 and a beta of 0.81. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.73. The company had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. Colgate-Palmolive’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period last year, the firm posted $0.73 EPS. On average, analysts anticipate that Colgate-Palmolive Company will post $2.90 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be paid a $0.40 dividend. The ex-dividend date is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 61.78%.
In other news, Director Ellen M. Hancock sold 5,057 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $71.91, for a total value of $363,648.87. Following the sale, the director now directly owns 199,777 shares in the company, valued at approximately $14,365,964.07. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Dennis J. Hickey sold 73,872 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the completion of the sale, the chief financial officer now owns 484,985 shares in the company, valued at $34,821,923. The disclosure for this sale can be found here. Insiders sold a total of 131,762 shares of company stock worth $9,443,766 over the last ninety days. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
What are top analysts saying about Colgate-Palmolive Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive Company and related companies.